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Abstract PMA-induced leukotriene C4 synthase (LTC4S)
phosphorylation was investigated over a period of 8 h in a
monocytic cell line (THP-1). The level of LTC4S phosphoryla-
tion was increased 3^5 fold over a 4 h period decreasing to basal
levels after 8 h. This phosphorylation event was found to be
specific to THP-1 cells as there was a lack of LTC4S
phosphorylation in both COS-7 and K-562 cells, and was also
found to be dependent on the cellular confluency. In the presence
of specific protein kinase C (PKC) inhibitors, a dose-dependent
inhibition of the phosphorylation of LTC4S became evident, an
effect not seen with PKA and tyrosine kinase inhibitors. This
represents the first direct demonstration of LTC4S phosphoryla-
tion in whole cells.
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1. Introduction
Cysteinyl leukotrienes (LTs), LTC4, LTD4, and LTE4 com-
prise the slow-reacting substance of anaphylaxis (SRS-A) and
are smooth muscle contractile lipid mediators with important
biological e¡ects elicited through G-protein coupled receptors
[1^4]. The formation of cysteinyl LTs is initiated by the acti-
vation of cytosolic phospholipase A2 (cPLA2) which liberates
arachidonic acid (AA) from phospholipids [5,6]. In the lipoxy-
genase pathway, AA binds to an integral membrane protein,
5-lipoxygenase-activating protein (FLAP), which is then pre-
sented to the soluble enzyme 5-lipoxygenase (5-LO). Via the
action of 5-LO, AA is converted to the unstable epoxide,
LTA4 [7]. At this point, LTA4 can follow one of two diver-
gent pathways within the cell of synthesis. Hydrolysis of
LTA4 through the action of cytosolic LTA4 hydrolase yields
the pro-in£ammatory mediator LTB4 [8]. Conjugation with
reduced glutathione (GSH) converts LTA4 to biologically ac-
tive LTC4, a stereospeci¢c reaction catalyzed by leukotriene
C4 synthase (LTC4S), an integral perinuclear membrane pro-
tein active as a homodimer [9]. LTC4 is then either exported
into the extracellular milieu directly, or is sequentially metab-
olized by the successive cleavage of glutamic acid and glycine
to generate LTD4 and LTE4 via a transpeptidase and a pep-
tidase, respectively [10,11].
Proteins in the leukotriene biosynthetic pathway are tightly
regulated and many require various co-factors for function
and full activity. Cytosolic PLA2 requires increased Ca2 con-
centrations in the WM range in conjunction with a serine
phosphorylation by MAP kinase at position 505 of cPLA2
for activation and translocation [12]. The reaction, catalyzed
by 5-LO, requires not only increases in Ca2 levels but also
ATP [13]. In whole cells, FLAP is an essential component for
5-LO activity [14^17]. Cytosolic LTA4 hydrolase has recently
been shown to be regulated by phosphorylation in endothelial
cells where under basal conditions the protein is phosphoryl-
ated at serine-415, leading to an inactive state of the enzyme.
Incubation with phosphatases reverts the protein to an active
state possessing epoxide hydrolase activity, thereby showing
that LTA4 hydrolase may be regulated by a kinase/phospha-
tase cycle [18].
The alternative pathway taken by LTA4 through the action
of LTC4S is its conjugation to GSH. LTC4S is an 18-kDa
protein which is neither dependent on any co-factors for ac-
tivity, requires post-translational modi¢cation by glycosyla-
tion nor formed as a pro-enzyme. Of interest are two putative
protein kinase C (PKC) consensus sites, Ser-Ala-Arg, found
on the protein at positions 28 and 111 [9,19]. These are sug-
gestive of LTC4S being subject to regulation by phosphoryla-
tion. Studies on the activity of LTC4S have been conducted in
our laboratory [20,21], and by other investigators [22], which
have also led to the same conclusions showing that the activ-
ity of LTC4S was attenuated upon activation of PKC by the
phorbol ester, PMA. This suggests the possibility of LTC4S
enzymatic activity being directly regulated by phosphorylation
of the enzyme.
2. Materials and methods
2.1. Cell culture
Cells from the human monocytic leukemic cell line THP-1 (ATCC),
and K-562 (ATCC), a lymphoid cell line, were both cultured in a
similar manner. Cells were maintained in sterile RPMI 1640 media
supplemented with 10% (v/v) heat-inactivated fetal bovine serum, 50
U/ml penicillin, 50 Wg/ml streptomycin, 0.05 mM 2-mercaptoethanol,
1 mM sodium pyruvate, 2 mM glutamine and 25 mM HEPES bu¡er
at pH 7.4. COS-7 cells (ATCC), a ¢broblast-like cell line, was main-
tained in Dulbecco’s modi¢ed Eagle’s medium supplemented with
10% (v/v) heat-inactivated fetal bovine serum, 50 U/ml penicillin,
and 50 Wg/ml streptomycin. Cells were grown at 37‡C in a humidi¢ed
atmosphere of 94% air and 6% CO2.
2.2. Creation of LTC4S-£ag
Human LTC4S cDNA (in pBluescript II KS, Invitrogen) was used
as a template for the introduction of a 5P Kozak translation initiation
consensus sequence (CCACC) and a £ag epitope (DYKDDDDK) at
the carboxyl terminus of LTC4S via PCR with the following oligonu-
cleotides: 5P CCG CTC GAG CGG CCG CGG ATC CAC CAT
GAA GGA CGA GGT AGC TCT ACT GGC TGC 3P and 5P
GCT CTA GAG CGG CCG CGG ATC CTA TTA TTT ATC
ATC ATC ATC TTT ATA ATC GGC CCA CGG CAG CAG
CGT CCG GAG CCG TC 3P.
A 25-cycle PCR reaction was run containing deoxynucleotides
(250 WM), cDNA template (1/100 of mini-prep), sense and antisense
primers (5 WM each), GC melt (Clontech) (1:5 by volume), and Pwo
DNA polymerase (2.5 units) in PCR bu¡er (10 Wl of 100 mM Tris-
HCl, pH 8.85 (20‡C), 250 mM KCl, 50 mM (NH4)2SO4, and 20 mM
MgSO4). The initial denaturing step was 2 min at 94‡C followed by
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25 cycles (94‡C for 1 min, 60‡C for 1 min, 72‡C for 1 min). The PCR
product was PCR puri¢ed (Qiagen), digested with XhoI and BamHI,
gel puri¢ed (Qiagen), ligated into pBluescript II KS (Rapid DNA
Ligation Kit from Boehringer Mannheim), and transformed into Epi-
curian Coli XL2 Blue Ultracompetent cells (Stratagene). Transform-
ants were selected on LB plates containing X-galactosidase (40 Wg/ml).
Several clones were picked, grown in culture, and the plasmid DNA
was prepared by miniprep (Qiagen). The orientation of the insert
(LTC4S-£ag) was con¢rmed by restriction digestion of the plasmid,
and the lack of any inadvertently incorporated mutations was ensured
with bi-directional sequencing using the ABI automated sequencer.
LTC4S-£ag/pBluescript was then subcloned into pcDNA3.1(+) (Invi-
trogen) for transfections into cell lines.
2.3. Transient transfection of COS-7 and K-562 cells
COS-7 cells were seeded a day prior to reach a con£uency of 50^
75% for transfections in 60-mm plates. Transfections of COS-7 cells
were performed using the Lipofectamine Plus method (Life Technol-
ogies). 10 Wg of LTC4S DNA was incubated for 15 min with 300 Wl of
Opti-MEM media and 5 Wl of Plus reagent followed by the addition of
Lipofectamine-Opti-MEM media (12 Wl Lipofectamine+300 Wl Opti-
MEM) which was further incubated for another 15 min. Culture me-
dia was removed from the plates and in place 2.4 ml of Opti-MEM
was added to the cells. DNA-Lipofectamine solution was then added
to these plates. Transfections were performed for 3 h at 37‡C in a 6%
CO2 atmosphere. DNA-Lipofectamine-Opti-MEM solution was then
aspirated and replaced with complete DMEM media and the cells
were then cultured at 37‡C with 6% CO2. Cells were then either
harvested after 40^48 h of incubation, assayed for protein concentra-
tion as per Bio-Rad, and subject to Western Blot analysis to detect
transfection e⁄ciency, or transfected cells were directly subjected to
32P-metabolic labeling followed by protein determination and Western
blot analysis.
Transfection into K-562 cells followed the same protocol as for
COS-7 cells with the following exceptions. DMEM media was re-
placed with RPMI 1640 and Opti-MEM was used to wash the cells
prior to transfection. The number of K-562 cells used per transfection
was 1U106 cells.
2.4. Phosphorylation of LTC4S into transfected cells
After transfections were complete, cells were washed twice with
phosphate-bu¡ered saline and then starved for 1 h at 37‡C, 6%
CO2 in 2 ml of phosphate-free DMEM medium. Cells were then
labeled with 0.5 mCi/ml of aqueous [32P]orthophosphate (10 mCi/ml
from Amersham) for 4 h and treated with or without 50 nM PMA for
appropriate activation times. Cells were subsequently harvested by a
wash with phosphate-bu¡ered saline followed by a spin at 4‡C. The
pellets were then resuspended in 1 ml of solubilization bu¡er (50 mM
Tris-HCl, pH 7.7, 1% (v/v) Triton X-100, 10% (v/v) glycerol, 100 mM
NaCl, 2.5 mM EGTA, 10 mM NaF, 0.2 mM vanadate and a cocktail
of protease inhibitors from Boehringer Mannheim) and vortexed to
ensure lysis. After a 10-min incubation on ice, the lysates were spun
down at 4‡C and the supernatant either frozen at 380‡C or used
immediately for Western blot analysis and immunoprecipitation of
LTC4S.
2.5. Endogenous phosphorylation of LTC4S in THP-1 cells
THP-1 cells grown to con£uency were washed once with phosphate-
bu¡ered saline and then resuspended at 2U106 cells/ml in phosphate-
free RPMI 1640, supplemented with 10% (v/v) dialyzed fetal bovine
serum for a 0.5 h starvation period at 37‡C and 6% CO2. Aqueous
[32P]orthophosphate (10 mCi/ml) was added to 1 mCi/ml, and treated
with or without 50 nM PMA for appropriate activation times in the
presence or absence of kinase inhibitors, and the cells were labeled for
a period of 4 h. Cells were subsequently harvested by centrifugation,
washed in phosphate-bu¡ered saline and lysed by vigorous vortexing
in 1 ml of solubilization bu¡er (components already described). The
lysates were then spun down and the supernatants were either stored
at 380‡C or processed immediately for level of LTC4S phosphoryla-
tion by immunoprecipitation and protein determination by Western
blot analysis.
2.6. Western blot analysis of cell lysates using anti-LTC4S antibody
SDS-containing Laemmli sample bu¡er was added to 100 Wg of
protein as measured by the Bio-Rad assay and the volume was ad-
justed equally with dH2O. The samples were subsequently heated for
5 min at 95‡C, electrophoresed through SDS-polyacrylamide gels (No-
vex), and electroblotted onto nitrocellulose membranes (Novex). Pon-
ceau S staining was used to visualize the e⁄ciency of transfer. Mem-
branes were then soaked for 1 h at 25‡C in Tris-bu¡ered saline
containing 0.1% (v/v) Tween 20 (0.1% T TBS; 20 mM Tris-HCl,
pH 7.5, 0.5 M NaCl) containing 5% (w/v) Bio-Rad Blotting Grade
Blocker non-fat dry milk. Blots were then washed twice for 5 min
each with 0.1% T TBS and subsequently treated for 1 h at 25‡C with
anti-LTC4S antibody (dilution 1:2000) in 0.05% T TBS containing 5%
milk. After washing the blots three times for 5 min each with 0.1% T
TBS the membranes were incubated for 1 h at 25‡C with a horse-
radish peroxidase-linked donkey anti-rabbit antibody (Amersham)
(dilution 1:3000) in 0.05% T TBS containing 1% milk. The blots
were washed three times for 5 min each with 0.3% T TBS and then
three times for 5 min each with 0.1% T TBS and subsequently devel-
oped using enhanced chemiluminescence (Renaissance Western Blot
Chemiluminescence Reagent, DuPont NEN), according to the manu-
facturer’s instructions.
2.7. Immunoprecipitation of LTC4S from labeled cells
Equivalent amounts of protein as measured by the Bio-Rad assay
were mixed with 500 Wl of immunoprecipitation bu¡er (10 mM Tris-
HCl pH 7.2, 1% (v/v) Triton X-100 and 300 mM NaCl) and incubated
on a rotator for 0.5 h at 4‡C followed by a 15 min spin at 14 000Ug in
an Eppendorf microfuge. LTC4S was then isolated from the super-
natants by immunoprecipitation using 20 Wl of anti-LTC4S antibody
prebound to protein A-Sepharose (Pharmacia). The immune complex
was then further incubated on a rotator for 1 h at 4‡C. The immune
complexes were collected by centrifugation for 5 min at 14 000Ug in
an Eppendorf microfuge, and the pellets were washed twice with 0.5 ml
of solubilization bu¡er (components described above) and twice with
0.5 ml of a more stringent wash bu¡er (50 mM NaF, 30 mM Na-
pyrophosphate, 0.2 mM vanadate). After the ¢nal wash the pellet was
aspirated to dryness and LTC4S was then eluted with 40 Wl of
2ULaemmli’s bu¡er. Samples were denatured by boiling for 5 min,
and following centrifugation the eluants were subject to SDS-PAGE.
2.8. SDS-PAGE and analysis of LTC4S
Aliquots of immunoprecipitated proteins were separated by SDS-
PAGE on 10^20% polyacrylamide gels. For autoradiography, gels
were ¢xed in 40% (v/v) methanol, 10% (v/v) acetic acid for 15 min
at room temperature, soaked in Enlightening for 20 min at room
temperature, dried at 80‡C at a ramp setting for a period of 2 h
and exposed to Kodak MR ¢lm for 2^3 days at room temperature.
Quantitation of proteins was done using a PhosphorImager (Molec-
ular Dynamics) with the phosphorscreen scanned after 1^2 days ex-
posure. For each experiment the area under the peak of the scans
which corresponded to the LTC4S band was used as a measure of
the amount of LTC4S in the sample. Although this determination is
not a measure of the absolute quantity of the protein in the samples,
these data provide a reliable estimate of relative di¡erences of levels of
LTC4S among the various samples.
3. Results
3.1. Evidence for phosphorylation of endogenous LTC4S and its
speci¢city to THP-1 cells
Examination of the deduced amino acid sequence of LTC4S
showed that the enzyme contains two PKC serine phospho-
rylation consensus sites at positions 28 and 111 [9,19]. It has
also been shown that activation of PKC by PMA leads to an
attenuation of LTC4S enzymatic activity [20^22]. To deter-
mine whether the inactivity of the enzyme might be due to a
post-translational modi¢cation by a protein kinase, we labeled
THP-1 cells with [32P]orthophosphate for a period of 4 h and
activated the cells with 50 nM PMA. The cells were then lysed
in a bu¡er containing protease and phosphatase inhibitors,
and endogenous LTC4S was recovered by immunoprecipita-
tion using a speci¢c polyclonal antibody raised against pep-
tides of LTC4S. The precipitate was then separated by SDS-
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PAGE, dried down, and exposed to X-ray ¢lm. Under these
conditions, incorporation of radioactive phosphate would in-
dicate that the native protein is phosphorylated.
LTC4S was found to be directly phosphorylated in THP-1
cells. The level of phosphorylation in THP-1 cells was seen to
increase by a factor of 3^5 fold as a result of PMA activation
for 4 h in comparison to the DMSO control, as measured by
autoradiography (Fig. 1).
In an attempt to determine whether the observed phospho-
rylation of LTC4S is a post-translational modi¢cation com-
mon to other cell types other than the human monocytic-like
THP-1 cell type, recombinant LTC4S was transfected into two
other cell types, namely COS-7, and K-562. Transfected cells
were then subjected to metabolic labeling with
[32P]orthophosphate, activation by PMA, followed by immu-
noprecipitation with anti-LTC4S antibody and detection by
SDS-PAGE-autoradiography. Transfections into both cell
lines were successful in view of the Western blotting results
in the presence of LTC4S DNA (Fig. 1). Both of these cell
lines were found to lack endogenous LTC4S as detected by
Western blotting of the mock transfections (data not shown).
As can be seen by the autoradiography results, LTC4S was
not phosphorylated in COS-7 cells nor in K-562 cells although
LTC4S protein was present. In contrast, endogenous LTC4S
in THP-1 cells was detected at the protein level and was found
to be phosphorylated (Fig. 1). This is indicative of the fact
that phorbol-ester induced PKC activity requires downstream
e¡ectors leading to the phosphorylation of LTC4S in THP-1
cells, which are absent in COS-7 and K-562 cell lines but
present in THP-1 cells. Therefore, phosphorylation of LTC4S
was observed only in THP-1 cells and thus was found to be
cell-speci¢c, requiring speci¢c e¡ector(s) (kinases and phos-
phatases) which impart the cell-speci¢city. Since phosphoryla-
tion of LTC4S was only evident in THP-1 cells, all further
studies were conducted using this system.
3.2. Phosphorylation of LTC4S is dependent on cell con£uency
Hyperphosphorylation of basal levels of endogenous
LTC4S was evident in certain experiments performed in the
process of assessing levels of phosphorylation in the absence
of any given stimuli (data not shown). To establish the nature
and possible cause of the observed hyperphosphorylation, it
was hypothesized that perhaps the cell con£uency had an
in£uence on the state of the cell, thereby a¡ecting signal trans-
duction processes. The level of phosphorylation of LTC4S was
tested at various starting THP-1 cell con£uencies from which
equal number of cells were used to metabolically label and
immunoprecipitate LTC4S. A pattern became evident where
the basal level of phosphorylation was found to increase as
the con£uency of the cell decreased from 1:5 to a 1:20 dilu-
tion without activation of PKC, as observed in the DMSO
control samples. The level of LTC4S phosphorylation in the
presence of PMA was not a¡ected with respect to the varying
cell con£uencies (Fig. 2). At a dilution of 1:50, cells were
found to aggregate and their growth hindered due to cell
clumping making it di⁄cult to assess their phosphorylation
state. This is suggestive of possible cell-cell interactions having
an e¡ect on the signaling of the cell. That is, it may be pos-
sible that such interactions may initiate a cascade of events
which leads to phosphorylation, perhaps via the activation of
a kinase(s) or a phosphatase(s). It is interesting that the PMA-
induced LTC4S phosphorylation was not a¡ected by the cell
con£uency. This is suggestive of the fact that these events may
be either independent of the PMA-induced phosphorylation
of LTC4S or perhaps the activation of PMA may overpower
the e¡ects due to cell-cell interaction. It should be noted that
all subsequent experiments were carried out with the cellular
dilution at 1:5, in order to minimize basal levels of phospho-
rylation.
3.3. Time-course of phosphorylation of endogenous LTC4S in
THP-1 cells
A time-course of the phosphorylation event was carried out
where cells were labeled for a period of 4 h and activated with
50 nM PMA for either 30 min, 1.5 h, 4 h, or 8 h (in which
case the cells were labeled for 8 h). Endogenous phospho-
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Fig. 2. The level of phosphorylation of LTC4S is dependent on the
cell con£uency. THP-1 cells at 1U106 cells/ml were seeded a week
prior to metabolic labeling at the following dilutions: 1:5, 1:10, and
1:20. Equivalent number of cells from the varied dilutions were la-
beled with 0.5 mCi/ml aqueous [32P]orthophosphate for 4 h and ac-
tivated with or without 50 nM PMA. Cells were then harvested,
solubilized, followed by immunoprecipitation of LTC4S with an
anti-LTC4S antibody pre-bound to protein A-Sepharose, washed,
separated by a 10^20% SDS-PAGE and visualized by autoradiogra-
phy. These data are a representation of three typical independent
experiments.
Fig. 1. Endogenous LTC4S is directly phosphorylated upon activa-
tion with PMA and is speci¢c to THP-1 cells. A: Western blot.
LTC4S was solubilized from transfected cells (COS-7 and K-562)
and from THP-1 cells as described in Section 2. Proteins (100 Wg)
in the presence of SDS-containing bu¡er were run on a 10^20%
SDS-PAGE and transferred to nitrocellulose, and LTC4S was de-
tected with a primary anti-LTC4S antibody and a secondary horse-
radish peroxidase-linked donkey anti-rabbit antibody. B: Autora-
diography. Equivalent numbers of LTC4S transfected cells and
THP-1 cells were metabolically labeled with 0.5 mCi/ml aqueous
[32P]orthophosphate for 4 h and activated with or without 50 nM
PMA. Cells were then harvested, solubilized, followed by immuno-
precipitation of LTC4S with an anti-LTC4S antibody pre-bound to
Protein A Sepharose, washed, separated by a 10^20% SDS-PAGE
and visualized by autoradiography. These data are typical of three
independent experiments.
N. Gupta et al./FEBS Letters 449 (1999) 66^7068
rylation was found to peak at 4 h and then decrease to basal
levels for both PMA activated cells and DMSO controls (Fig.
3).
Of interest was the trend observed with the DMSO vehicle
controls where the level of phosphorylation was also seen to
increase up to 4 h and then return to basal levels at 8 h. This
con¢rms that the observed phosphorylation event was not
only a consequence of induction by PMA but is also signi¢-
cant physiologically under no stimulus and follows a partic-
ular kinetic pro¢le. The same trend was evident in the absence
of DMSO thereby con¢rming that the trend was not an arti-
fact due to DMSO (data not shown).
3.4. Inhibition of LTC4S phosphorylation by PKC-speci¢c
inhibitors
In order to shed light on the protein kinase responsible for
the phosphorylation of LTC4S, inhibitors of PKC, PKA, and
of tyrosine kinase were tested for their ability to block the
observed PMA-mediated phosphorylation. Staurosporine, bis-
indolylmaleimide, and GF109203X, all speci¢c inhibitors of
PKC, dose-dependently attenuated the phosphorylation of
LTC4S evoked by PMA (Fig. 4). The e¡ects of staurosporine
were apparent at a concentration of 0.1 WM, bisindolylmale-
imide was e¡ective at 1 WM, and GF109203X at 7.5 WM.
These PKC inhibitors were found to be capable of attenuating
the level of phosphorylation to basal levels and below at high-
er inhibitor concentrations. In contrast, inhibitors of tyrosine
kinase, namely, herbimycin and tyrophostin and of PKA,
KT5270, were found to produce no inhibition. This evidence
suggests a PKC-mediated cascade of events either directly or
via other proteins, leading to the phosphorylation of LTC4S,
and is in accordance with previous studies on PMA-mediated
attenuation of LTC4S activity being restored upon treatment
with inhibitors of PKC.
4. Discussion
Several independent studies have demonstrated downregu-
lation of LTC4S enzymatic activity by phosphorylation, ini-
tiated by a cascade of kinases, in particular PKC [20^22].
LTC4S activity measured in neutrophilic [21], and eosinophilic
[20] cell lines and in human granulocytes [22], challenged with
PMA have demonstrated that the activity was inhibited result-
ing in an attenuation of cysteinyl LTs without a¡ecting non-
cysteinyl LT biosynthesis. Moreover, the attenuation of the
activity was completely prevented in the presence of inhibitors
of PKC but not by inhibitors of tyrosine kinase nor protein
kinase A. The presence of two putative PKC consensus sites
on LTC4S was another indicator for the potential for LTC4S
phosphoregulation [9,19]. Prior to the present study, there was
no evidence of a direct phosphorylation event upon LTC4S.
This study clearly indicates that LTC4S is phosphorylated at
the protein level in THP-1 cells, not only in response to PMA
activation, but also at a lower basal level which may be at-
tributed to a pool of LTC4S which consists of both phos-
phorylated and non-phosphorylated forms of the enzyme.
Therefore in our study, the levels of phosphorylation were
compared with basal phosphorylation levels.
The lack of LTC4S phosphorylation in COS-7 and K-562
cells indicates THP-1 cell-speci¢city. Numerous reasons may
explain this observed speci¢city, including the lack of an ap-
propriate target for PMA, downstream e¡ectors, and the lo-
calization of LTC4S in these cells as compared to THP-1 cells.
An interesting observation was made from the time-course
of activation which revealed that the phosphorylation event
followed a particular kinetic pro¢le. The level of LTC4S phos-
phorylation was seen to increase with time of PMA activation
up to 4 h, after which the enzyme became dephosphorylated
to basal levels after 8 h of activation, suggesting a negative
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Fig. 4. Phosphorylation of LTC4S is a PKC-mediated event. THP-1
cells were grown to con£uency and labeled with 0.5 mCi/ml aqueous
[32P]orthophosphate for a period of 4 h. During labeling, cells were
treated with or without 50 nM PMA in the presence or absence of
a range of kinase inhibitor concentrations. Staurosporine, 0.05^
10 WM; bisindolylmaleimide, 0.5^10 WM; GF109203X, 0.5^10 WM;
tyrophostin, 10 WM; herbimycin, 10 WM; and KT5720, 1 WM. Cells
were then harvested, solubilized, followed by immunoprecipitation
of LTC4S with an anti-LTC4S antibody pre-bound to protein
A-Sepharose, washed, separated by a 10^20% SDS-PAGE and vis-
ualized by autoradiography. Represented data is one of three typical
independent experiments.
Fig. 3. Time course of the phosphorylation of endogenous LTC4S
in THP-1 cells. Con£uent THP-1 cells were labeled for a period of
4 h with 0.5 mCi/ml aqueous [32P]orthophosphate and activated
with or without 50 nM PMA for either 30 min, 1.5 h, 4 h, or 8 h
(in which case the cells were labeled for 8 h). Cells were then har-
vested, solubilized, followed by immunoprecipitation of LTC4S with
an anti-LTC4S antibody pre-bound to protein A-Sepharose, washed,
separated by a 10^20% SDS-PAGE and visualized by autoradiogra-
phy. Four independent experiments were performed and represented
here is one typical one.
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feedback mechanism. This feedback loop may generate signals
which may allow the enzyme to dephosphorylate itself, return-
ing the enzyme to its active state. The slight increase seen in
the level of LTC4S phosphorylation in the DMSO control
samples (Fig. 3) can be attributed to the exchange of endog-
enous 31P for 32P.
The level of phosphorylation was markedly in£uenced by
the cellular density. A recent study in NIH 3T3 mouse ¢bro-
blasts showed that as cells became con£uent the phosphoryl-
ation of c-Jun following UVC irradiation or growth factor
stimulation was strongly inhibited. It was also demonstrated
that this inhibition was due to the inhibition of the activation
of the stress kinase pathways (JNK/SAPKs and p38) whereas
classical MAPK activation was not a¡ected by cell density
[23]. Other than possible cell-cell interactions, a di¡erence in
cell density can also result in a change in numerous other
parameters. For example, the pH and the acidity of the media
may be in£uenced by the con£uency leading to a change in
the environment of the cell. These changes may in turn e¡ect
the behavior of the cell and its state of basal levels of phos-
phorylation. In order to avoid artifactual interferences as a
result of this e¡ect, the con£uency at which the cells were used
throughout the study was kept constant.
The inhibitor pro¢le of this and previous studies indicates
that protein kinase C is either directly or indirectly responsible
for LTC4S phosphorylation. There have been reported to be
up to 11 isoforms of PKC present in either cytosolic or nu-
clear pools [24]. THP-1 cells have been examined for the pres-
ence of K, L, Q, N and O classes of PKC and only K and N are
expressed in this cell line [25], which suggests that one of the
two may be the kinase which regulates LTC4S.
In summary, we have demonstrated for the ¢rst time that
LTC4S is directly phosphorylated in THP-1 cells at the pro-
tein level, an event which is initiated speci¢cally by protein
kinase C. Mutagenic analyses of LTC4S has recently shown
the involvement of residues arginine-51 and tyrosine-93 for
the opening of the epoxide ring of LTA4 and the activation
of GSH, respectively [26]. Determination of the site(s) of
phosphorylation would shed light on the mechanism by which
the enzyme loses its activity. Phosphorylation may cause a
change in the 3-dimensional structure of the enzyme, sterically
hinder the substrate binding sites, directly prevent substrate
interaction or activation, or perhaps allow for another inhib-
itory entity to interact with LTC4S, all leading to the down-
regulation of its activity.
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